Hoch Lynelle - Insider Non-Derivative Transactions at BRISTOL MYERS SQUIBB CO (BMY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 10, 2024, Hoch Lynelle's relationship to BRISTOL MYERS SQUIBB CO (BMY) is Officer (President, Cell Therapy Org.), and currently has 3,781 shares of Common Stock, $0.10 par value.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BMY insiders.
Data Source: SEC.
Hoch Lynelle - Insider Non-Derivative Transactions at BMY
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Mar 11, 2024 | F -- (Common Stock, $0.10 par value) | 197 | 53.79 | 257 |
Mar 11, 2024 | J -- (Common Stock, $0.10 par value) | 85 | 0 | 454 |
Mar 11, 2024 | F -- (Common Stock, $0.10 par value) | 194 | 53.79 | 513 |
Mar 11, 2024 | M -- (Common Stock, $0.10 par value) | 539 | 0 | 539 |
Mar 11, 2024 | J -- (Common Stock, $0.10 par value) | 94 | 0 | 707 |
Mar 11, 2024 | M -- (Common Stock, $0.10 par value) | 544 | 0 | 801 |
Mar 11, 2024 | F -- (Common Stock, $0.10 par value) | 917 | 53.79 | 1726 |
Mar 11, 2024 | J -- (Common Stock, $0.10 par value) | 1138 | 0 | 2643 |
Mar 11, 2024 | M -- (Common Stock, $0.10 par value) | 3268 | 0 | 3781 |